TELEMEDICINE APPOINTMENTS: WE ARE ASKING ALL PATIENTS WITH DIABETES TO UPLOAD THEIR DEVICES AT HOME*. PLEASE GO TO PATIENT RESOURCES AND SELECT THE "UPLOADING DIABETES PUMPS, CGMS AND METERS" DROPDOWN TO VIEW ALL UPLOADING RESOURCES AND INSTRUCTION.
* IMPORTANT ANNOUNCEMENT: After utilizing the Diasend platform for in clinic uploading as well as the primary option for patients to upload from home, the Diabetes and Endocrinology Center is now using the Glooko platform for uploading, due to the Diasend platform being discontinued for clinic use in the USA. Please see instructions on how to sign up, upload and share your diabetes technology data with our clinic through Glooko on the Patient Resources page referenced above. In addition to the Glooko platform, resources for the Dexcom, Freestyle Libre, Medtronic Carelink, Tandem T:Connect and InPen are available.
Welcome to the USF Diabetes and Endocrinology Center. We are this region’s epicenter for diabetes and endocrinology treatment, research, and education – offering a multidisciplinary team of providers who are specially trained to diagnose, treat, and engage with patients and their families to manage complex diabetes and endocrine disorders.
The USF Diabetes and Endocrinology Center, as part of USF Health, is this region’s only academic medical center, provides a level of expertise that is unmatched in the Tampa Bay area. Our clinical team includes three pediatric and three adult board-certified endocrinologists, two adult endocrine nurse practitioners, a clinical social worker, and two registered dietitians as well as three diabetes educators specializing in diabetes technology training; working with a clinical support team to meet the needs of our patients. In addition to our multidisciplinary diabetes program, our providers care for a full spectrum of hormone-related conditions including bone and calcium, thyroid, growth, adrenal, pubertal, menopausal, and transgender concerns that may lead to, short stature, early or late puberty, atypical sexual development. pituitary disease, polycystic ovarian syndrome and infertility, and adrenal disorders
In addition, our center is recognized worldwide as a premier research center for diabetes. Our commitment to research is evidenced by our recognition as global leader in diabetes research. Our Center is funded by the National Institutes of Health as one of 20 Type 1 Diabetes TrialNet Clinical Centers worldwide. We collaborate with academic and industry partners to advance therapies and technologies to better enable patients to manage their disease and to ultimately prevent and cure diabetes and related endocrine disorders.
Please access the following forms, so we will be able to provide you with the best possible care:
States are rolling out their COVID-19 vaccination plans, and some states are not giving people with type 1 and type 2 diabetes equal access to the vaccine. Vaccination is an important tool to protect everyone with diabetes and end the pandemic, which clinical evidence has shown puts people with diabetes at increased risk for severe illness.
That's where ADA needs your voice: Will you ask your Governor to prioritize all people with diabetes for the vaccine?
Over 5,000 ADA Advocates have contacted their governors already, but we are going to need more people to break through. Join us today, and help spread the word by sharing this with your family, friends, and networks.
Making this change is time-sensitive, as states are now operationalizing vaccine rollouts.
Together, we'll keep working to ensure decision makers understand that people with diabetes have been disparately impacted by the pandemic and must be prioritized in vaccine distribution plans. Join us in contacting your governor today.
ADA AdvocacyP.S. Get the latest information on ADA's COVID-19 Hub and COVID-19 Vaccination Guide to keep yourself and others healthy.